Notice

This is not the latest version of this item. The latest version can be found at:https://dspace.mit.edu/handle/1721.1/135559.2

Show simple item record

dc.contributor.authorNguyen, Tam NT
dc.contributor.authorSha, Sha
dc.contributor.authorHong, Moo Sun
dc.contributor.authorMaloney, Andrew J
dc.contributor.authorBarone, Paul W
dc.contributor.authorNeufeld, Caleb
dc.contributor.authorWolfrum, Jacqueline
dc.contributor.authorSprings, Stacy L
dc.contributor.authorSinskey, Anthony J
dc.contributor.authorBraatz, Richard D
dc.date.accessioned2021-10-27T20:24:01Z
dc.date.available2021-10-27T20:24:01Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/1721.1/135559
dc.description.abstractManufacturing of recombinant adeno-associated virus (rAAV) viral vectors remains challenging, with low yields and low full:empty capsid ratios in the harvest. To elucidate the dynamics of recombinant viral production, we develop a mechanistic model for the synthesis of rAAV viral vectors by triple plasmid transfection based on the underlying biological processes derived from wild-type AAV. The model covers major steps starting from exogenous DNA delivery to the reaction cascade that forms viral proteins and DNA, which subsequently result in filled capsids, and the complex functions of the Rep protein as a regulator of the packaging plasmid gene expression and a catalyst for viral DNA packaging. We estimate kinetic parameters using dynamic data from literature and in-house triple transient transfection experiments. Model predictions of productivity changes as a result of the varied input plasmid ratio are benchmarked against transfection data from the literature. Sensitivity analysis suggests that (1) the poorly coordinated timeline of capsid synthesis and viral DNA replication results in a low ratio of full virions in harvest, and (2) repressive function of the Rep protein could be impeding capsid production at a later phase. The analyses from the mathematical model provide testable hypotheses for evaluation and reveal potential process bottlenecks that can be investigated.
dc.language.isoen
dc.publisherElsevier BV
dc.relation.isversionof10.1016/j.omtm.2021.04.006
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs License
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceElsevier
dc.titleMechanistic Model for Production of Recombinant Adeno-associated Virus via Triple Transfection of HEK293 Cells
dc.typeArticle
dc.relation.journalMolecular Therapy — Methods & Clinical Development
dc.eprint.versionFinal published version
dc.type.urihttp://purl.org/eprint/type/JournalArticle
eprint.statushttp://purl.org/eprint/status/PeerReviewed
dc.date.updated2021-08-02T18:14:29Z
dspace.orderedauthorsNguyen, TNT; Sha, S; Hong, MS; Maloney, AJ; Barone, PW; Neufeld, C; Wolfrum, J; Springs, SL; Sinskey, AJ; Braatz, RD
dspace.date.submission2021-08-02T18:14:31Z
mit.journal.volume21
mit.licensePUBLISHER_CC
mit.metadata.statusAuthority Work and Publication Information Needed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

VersionItemDateSummary

*Selected version